Literature DB >> 10772368

Underuse of inhaled corticosteroids in adults with asthma.

N Yuksel1, S Ginther, P Man, R T Tsuyuki.   

Abstract

Despite strong evidence that inhaled corticosteroids are beneficial in treating asthma, a number of small studies suggest a use rate of only 34-56%. The primary objective of this study was to determine patterns of prescribing inhaled corticosteroids for high-risk patients with asthma. Secondary objectives were to assess patterns of practice with respect to other agents prescribed before and at hospital discharge, and to determine if an emergency room asthma care map at one of the study hospitals was being followed. We retrospectively reviewed charts of 1022 patients with an acute attack of asthma treated in the emergency rooms of the Royal Alexandra Hospital and University of Alberta Hospital from January 1, 1996, to March 31, 1997. A forward stepwise logistic regression analysis was performed with the dependent variable defined as whether or not the patient was using an inhaled or oral corticosteroid during the index visit, and the independent variable being all major demographic variables. Inhaled corticosteroids were prescribed for 460 patients (52.0%) at the index visit. Overall, antiinflammatory drugs were prescribed for 548 patients (62.1%). An asthma care map was followed for 107 (16.8%) patients treated at the Royal Alexandra Hospital at the index visit. Logistic regression analysis showed that women and patients with more than one emergency room visit most likely were to be using inhaled or inhaled plus oral corticosteroids at the index visit. Documentation of drug therapy at discharge was poor for 42% of patients; therefore, analysis of practice patterns in this group was not attempted. This study shows that inhaled corticosteroids were prescribed for only about one-half of patients with an acute asthma attack. Given this low use by high-risk patients, the need for programs designed to improve asthma therapy is evident.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772368     DOI: 10.1592/phco.20.5.387.35050

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  5 in total

1.  Assessment of inhaled corticosteroids use and associated factors among asthmatic patients attending Tikur Anbessa Specialized Hospital, Ethiopia.

Authors:  Yohanes Ayele; Ephrem Engidawork; Tola Bayisa
Journal:  BMC Res Notes       Date:  2017-07-25

2.  Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia.

Authors:  May Chien Chin; Sheamini Sivasampu; Ee Ming Khoo
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

3.  Evaluation of pharmacotherapy of obstructive airway diseases in the Montenegrin outpatient care: comparison with two Scandinavian countries.

Authors:  Natasha Duborija-Kovacevic; Milica Martinovic
Journal:  Multidiscip Respir Med       Date:  2012-06-21

4.  Barriers to asthma treatment in the United States: results from the global asthma physician and patient survey.

Authors:  Michael S Blaiss; Michael A Kaliner; Carlos E Baena-Cagnani; Ronald Dahl; Erkka J Valovirta; Giorgio W Canonica
Journal:  World Allergy Organ J       Date:  2009-12       Impact factor: 4.084

Review 5.  Modification of provider behavior to achieve improved asthma outcomes.

Authors:  Erika M Jones; Jay M Portnoy
Journal:  Curr Allergy Asthma Rep       Date:  2003-11       Impact factor: 4.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.